 Johan Van Hove
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperglycinemia, Nonketotic | 8 | 2019 | 42 | 3.260 |
Why?
| | DNA, Mitochondrial | 6 | 2021 | 182 | 2.060 |
Why?
| | Mitochondrial Diseases | 7 | 2024 | 76 | 1.850 |
Why?
| | Epilepsy | 7 | 2022 | 278 | 1.730 |
Why?
| | Mitochondrial Proteins | 5 | 2021 | 213 | 1.490 |
Why?
| | Aldehyde Dehydrogenase | 6 | 2022 | 102 | 1.450 |
Why?
| | Mutation | 16 | 2021 | 3338 | 1.350 |
Why?
| | Mitochondria | 6 | 2021 | 744 | 1.130 |
Why?
| | Pyridoxine | 5 | 2022 | 28 | 1.000 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 33 | 0.880 |
Why?
| | Alagille Syndrome | 1 | 2024 | 35 | 0.880 |
Why?
| | Glycine | 4 | 2016 | 152 | 0.840 |
Why?
| | Cardiomyopathies | 2 | 2021 | 298 | 0.810 |
Why?
| | Infant | 25 | 2021 | 7943 | 0.810 |
Why?
| | Corpus Callosum | 2 | 2019 | 56 | 0.790 |
Why?
| | Leukoencephalopathies | 2 | 2019 | 21 | 0.790 |
Why?
| | Biliary Atresia | 1 | 2024 | 185 | 0.750 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 70 | 0.730 |
Why?
| | White Matter | 2 | 2019 | 105 | 0.730 |
Why?
| | Lysine | 4 | 2022 | 241 | 0.710 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 244 | 0.710 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 33 | 0.670 |
Why?
| | Energy Metabolism | 3 | 2015 | 727 | 0.660 |
Why?
| | Protein Biosynthesis | 1 | 2021 | 386 | 0.640 |
Why?
| | Magnetic Resonance Imaging | 10 | 2020 | 3039 | 0.640 |
Why?
| | Thalamus | 1 | 2019 | 74 | 0.640 |
Why?
| | Diseases in Twins | 1 | 2019 | 174 | 0.620 |
Why?
| | Infant, Newborn | 14 | 2021 | 5038 | 0.580 |
Why?
| | Vitamin B Complex | 2 | 2015 | 38 | 0.560 |
Why?
| | Leigh Disease | 3 | 2015 | 17 | 0.560 |
Why?
| | Mutation, Missense | 2 | 2016 | 294 | 0.550 |
Why?
| | Glycine Decarboxylase Complex | 1 | 2016 | 5 | 0.540 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2016 | 6 | 0.540 |
Why?
| | Aminomethyltransferase | 1 | 2016 | 8 | 0.540 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.480 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.480 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 16 | 0.480 |
Why?
| | Mitochondrial Myopathies | 2 | 2023 | 4 | 0.470 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.450 |
Why?
| | Glutaredoxins | 1 | 2013 | 11 | 0.450 |
Why?
| | Arginine | 1 | 2015 | 236 | 0.450 |
Why?
| | Genetic Variation | 2 | 2021 | 868 | 0.450 |
Why?
| | Spasm | 1 | 2013 | 19 | 0.440 |
Why?
| | Neurodevelopmental Disorders | 1 | 2015 | 110 | 0.440 |
Why?
| | DNA Mutational Analysis | 8 | 2019 | 373 | 0.400 |
Why?
| | Amino Acids | 1 | 2015 | 445 | 0.380 |
Why?
| | Seizures | 3 | 2011 | 337 | 0.380 |
Why?
| | Liver Diseases | 2 | 2013 | 254 | 0.380 |
Why?
| | Metabolic Diseases | 2 | 2010 | 98 | 0.380 |
Why?
| | Channelopathies | 1 | 2011 | 5 | 0.380 |
Why?
| | Humans | 44 | 2024 | 114045 | 0.370 |
Why?
| | Neurotransmitter Agents | 1 | 2011 | 75 | 0.360 |
Why?
| | Succinate-CoA Ligases | 1 | 2010 | 4 | 0.360 |
Why?
| | Brain Diseases, Metabolic | 1 | 2010 | 7 | 0.360 |
Why?
| | Brain | 6 | 2019 | 2355 | 0.350 |
Why?
| | Neurogenesis | 1 | 2011 | 102 | 0.340 |
Why?
| | Ophthalmoplegia, Chronic Progressive External | 1 | 2009 | 3 | 0.330 |
Why?
| | Anticonvulsants | 2 | 2010 | 178 | 0.320 |
Why?
| | Female | 26 | 2023 | 59324 | 0.320 |
Why?
| | Nutrition Therapy | 1 | 2009 | 30 | 0.320 |
Why?
| | Holocarboxylase Synthetase Deficiency | 1 | 2008 | 2 | 0.320 |
Why?
| | Carbon-Nitrogen Ligases | 1 | 2008 | 4 | 0.320 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1310 | 0.320 |
Why?
| | Biotin | 1 | 2008 | 20 | 0.310 |
Why?
| | Male | 25 | 2023 | 55396 | 0.300 |
Why?
| | DNA Helicases | 1 | 2009 | 133 | 0.300 |
Why?
| | Proteins | 1 | 2013 | 906 | 0.290 |
Why?
| | RNA, Transfer, Glu | 1 | 2007 | 5 | 0.290 |
Why?
| | Practice Guidelines as Topic | 2 | 2013 | 1381 | 0.280 |
Why?
| | Oxidative Phosphorylation | 2 | 2021 | 154 | 0.280 |
Why?
| | Child, Preschool | 11 | 2019 | 9114 | 0.270 |
Why?
| | Child | 15 | 2024 | 18401 | 0.270 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2783 | 0.260 |
Why?
| | GTP Cyclohydrolase | 1 | 2006 | 7 | 0.260 |
Why?
| | Paraparesis, Spastic | 1 | 2006 | 2 | 0.260 |
Why?
| | Dystonia | 1 | 2006 | 16 | 0.260 |
Why?
| | Fatal Outcome | 3 | 2013 | 281 | 0.260 |
Why?
| | RNA, Transfer, Asp | 1 | 2005 | 2 | 0.250 |
Why?
| | Parkinsonian Disorders | 1 | 2006 | 28 | 0.250 |
Why?
| | Tremor | 1 | 2006 | 45 | 0.250 |
Why?
| | Polymers | 1 | 2009 | 448 | 0.250 |
Why?
| | Fibroblasts | 3 | 2019 | 834 | 0.250 |
Why?
| | Benzoic Acid | 1 | 2005 | 4 | 0.240 |
Why?
| | Heterozygote | 3 | 2017 | 250 | 0.240 |
Why?
| | Benzoates | 1 | 2005 | 38 | 0.240 |
Why?
| | Eye | 2 | 2019 | 97 | 0.240 |
Why?
| | Amino Acid Sequence | 5 | 2015 | 1981 | 0.230 |
Why?
| | Glucose | 1 | 2009 | 899 | 0.230 |
Why?
| | Brain Diseases | 3 | 2015 | 124 | 0.230 |
Why?
| | Genotype | 3 | 2019 | 1757 | 0.220 |
Why?
| | Phenotype | 5 | 2019 | 2784 | 0.220 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2003 | 3 | 0.220 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2003 | 14 | 0.220 |
Why?
| | Pedigree | 3 | 2019 | 460 | 0.200 |
Why?
| | Point Mutation | 2 | 2017 | 216 | 0.190 |
Why?
| | 2-Aminoadipic Acid | 2 | 2019 | 8 | 0.190 |
Why?
| | Adolescent | 10 | 2020 | 17800 | 0.190 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2020 | 8 | 0.170 |
Why?
| | External Capsule | 1 | 2019 | 2 | 0.170 |
Why?
| | Thymidine Phosphorylase | 1 | 2020 | 12 | 0.170 |
Why?
| | NADH Dehydrogenase | 1 | 2019 | 17 | 0.170 |
Why?
| | Porencephaly | 1 | 2019 | 6 | 0.160 |
Why?
| | Collagen Type IV | 1 | 2019 | 22 | 0.160 |
Why?
| | Biomarkers | 2 | 2024 | 3397 | 0.160 |
Why?
| | Twins, Monozygotic | 1 | 2019 | 210 | 0.160 |
Why?
| | Spectrum Analysis | 1 | 2019 | 83 | 0.160 |
Why?
| | Lactic Acid | 1 | 2019 | 272 | 0.150 |
Why?
| | Liver | 3 | 2015 | 1633 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2019 | 474 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 176 | 0.140 |
Why?
| | Cell Respiration | 2 | 2015 | 71 | 0.140 |
Why?
| | Acyl-CoA Dehydrogenase | 2 | 2009 | 8 | 0.140 |
Why?
| | Dihydrolipoamide Dehydrogenase | 1 | 2016 | 7 | 0.130 |
Why?
| | Cataract | 1 | 2019 | 184 | 0.130 |
Why?
| | Gene Expression | 2 | 2015 | 1417 | 0.130 |
Why?
| | Prognosis | 2 | 2015 | 3315 | 0.130 |
Why?
| | Introns | 1 | 2016 | 227 | 0.120 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 30 | 0.120 |
Why?
| | Exons | 1 | 2016 | 301 | 0.120 |
Why?
| | Lysosomal Storage Diseases | 1 | 2015 | 4 | 0.120 |
Why?
| | Diet Therapy | 1 | 2015 | 36 | 0.120 |
Why?
| | COS Cells | 1 | 2015 | 175 | 0.120 |
Why?
| | Dyskinesias | 1 | 2015 | 11 | 0.120 |
Why?
| | Mental Retardation, X-Linked | 1 | 2015 | 13 | 0.120 |
Why?
| | Amino Acyl-tRNA Synthetases | 1 | 2015 | 28 | 0.120 |
Why?
| | Treatment Outcome | 6 | 2023 | 9049 | 0.120 |
Why?
| | Cerebrospinal Fluid | 1 | 2015 | 90 | 0.120 |
Why?
| | Electron Transport | 1 | 2015 | 108 | 0.120 |
Why?
| | Protein Structure, Secondary | 1 | 2015 | 325 | 0.120 |
Why?
| | Demyelinating Diseases | 1 | 2015 | 73 | 0.120 |
Why?
| | Base Sequence | 2 | 2010 | 2114 | 0.110 |
Why?
| | Cell Line | 1 | 2019 | 2629 | 0.110 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 82 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 3 | 2013 | 2090 | 0.110 |
Why?
| | Genes, X-Linked | 1 | 2013 | 16 | 0.110 |
Why?
| | Muscles | 1 | 2015 | 320 | 0.110 |
Why?
| | Genetic Testing | 1 | 2016 | 381 | 0.110 |
Why?
| | Host Cell Factor C1 | 1 | 2013 | 13 | 0.110 |
Why?
| | Hyperhomocysteinemia | 1 | 2013 | 24 | 0.110 |
Why?
| | Alleles | 1 | 2016 | 789 | 0.110 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2013 | 21 | 0.110 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2013 | 20 | 0.110 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2013 | 2 | 0.110 |
Why?
| | Atrophy | 1 | 2013 | 152 | 0.110 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 23 | 0.110 |
Why?
| | Liver Transplantation | 1 | 2020 | 695 | 0.110 |
Why?
| | Stilbenes | 1 | 2013 | 36 | 0.110 |
Why?
| | Vitamin B 12 | 1 | 2013 | 115 | 0.100 |
Why?
| | Sequence Alignment | 2 | 2015 | 323 | 0.100 |
Why?
| | Quality of Life | 1 | 2023 | 2343 | 0.100 |
Why?
| | DNA | 1 | 2019 | 1350 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 949 | 0.100 |
Why?
| | Urea Cycle Disorders, Inborn | 1 | 2011 | 22 | 0.100 |
Why?
| | Genetic Association Studies | 2 | 2010 | 339 | 0.100 |
Why?
| | Time | 1 | 2011 | 70 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2019 | 12521 | 0.090 |
Why?
| | Vitamin B 6 | 1 | 2011 | 9 | 0.090 |
Why?
| | Dietary Supplements | 1 | 2015 | 459 | 0.090 |
Why?
| | Age of Onset | 3 | 2013 | 444 | 0.090 |
Why?
| | Cystathionine beta-Synthase | 1 | 2011 | 59 | 0.090 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 1791 | 0.090 |
Why?
| | Homocystinuria | 1 | 2011 | 62 | 0.090 |
Why?
| | Sirtuin 3 | 1 | 2011 | 51 | 0.090 |
Why?
| | Diffuse Cerebral Sclerosis of Schilder | 1 | 2010 | 4 | 0.090 |
Why?
| | Adult | 6 | 2020 | 30375 | 0.090 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 163 | 0.090 |
Why?
| | Chemokines | 1 | 2011 | 215 | 0.090 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2010 | 44 | 0.080 |
Why?
| | Myocardium | 1 | 2015 | 911 | 0.080 |
Why?
| | Biogenic Monoamines | 1 | 2009 | 13 | 0.080 |
Why?
| | Structure-Activity Relationship | 1 | 2010 | 499 | 0.080 |
Why?
| | Leucovorin | 1 | 2009 | 43 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 476 | 0.080 |
Why?
| | Pregnancy Complications | 2 | 2011 | 430 | 0.080 |
Why?
| | Neonatal Screening | 1 | 2010 | 151 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 4402 | 0.080 |
Why?
| | Sequence Deletion | 1 | 2009 | 166 | 0.080 |
Why?
| | Fatty Liver | 1 | 2011 | 209 | 0.080 |
Why?
| | Nervous System Diseases | 1 | 2011 | 254 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2009 | 218 | 0.080 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 308 | 0.080 |
Why?
| | Developmental Disabilities | 1 | 2010 | 236 | 0.070 |
Why?
| | Protein Conformation | 1 | 2010 | 803 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2011 | 1331 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2537 | 0.070 |
Why?
| | Diet | 3 | 2012 | 1080 | 0.070 |
Why?
| | Reflex, Abnormal | 1 | 2006 | 7 | 0.070 |
Why?
| | Young Adult | 2 | 2011 | 10444 | 0.060 |
Why?
| | Phenylalanine | 1 | 2006 | 57 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2011 | 4392 | 0.060 |
Why?
| | Tendinopathy | 1 | 2006 | 22 | 0.060 |
Why?
| | Models, Molecular | 1 | 2010 | 1368 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2013 | 3861 | 0.060 |
Why?
| | Physicians | 1 | 2013 | 765 | 0.060 |
Why?
| | Kinetics | 1 | 2008 | 1547 | 0.060 |
Why?
| | Sodium Benzoate | 1 | 2005 | 5 | 0.060 |
Why?
| | Amino Acid Oxidoreductases | 1 | 2005 | 18 | 0.060 |
Why?
| | Practice Patterns, Physicians' | 1 | 2013 | 1175 | 0.060 |
Why?
| | Transferases | 1 | 2005 | 28 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 330 | 0.060 |
Why?
| | Psychomotor Disorders | 1 | 2004 | 17 | 0.060 |
Why?
| | Multienzyme Complexes | 1 | 2005 | 64 | 0.060 |
Why?
| | Motor Skills Disorders | 1 | 2005 | 23 | 0.060 |
Why?
| | Merozoite Surface Protein 1 | 1 | 2023 | 2 | 0.050 |
Why?
| | Stereoisomerism | 1 | 2003 | 91 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 990 | 0.050 |
Why?
| | Circadian Rhythm | 1 | 2006 | 356 | 0.050 |
Why?
| | Lower Extremity | 1 | 2006 | 334 | 0.050 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 219 | 0.050 |
Why?
| | Pregnancy | 2 | 2011 | 5499 | 0.050 |
Why?
| | Biopsy | 1 | 2005 | 1024 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 294 | 0.050 |
Why?
| | Cognition | 2 | 2022 | 990 | 0.050 |
Why?
| | Pipecolic Acids | 2 | 2012 | 23 | 0.050 |
Why?
| | Colorado | 1 | 2010 | 4090 | 0.050 |
Why?
| | Carrier Proteins | 1 | 2005 | 694 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2010 | 1468 | 0.040 |
Why?
| | Thymidine | 1 | 2020 | 58 | 0.040 |
Why?
| | Esophageal Motility Disorders | 1 | 2020 | 23 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 1656 | 0.040 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2020 | 120 | 0.040 |
Why?
| | Animals | 3 | 2015 | 31565 | 0.040 |
Why?
| | Models, Biological | 1 | 2005 | 1611 | 0.040 |
Why?
| | Age Factors | 1 | 2005 | 2885 | 0.040 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 8 | 0.030 |
Why?
| | Aminoacylation | 1 | 2015 | 12 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2020 | 519 | 0.030 |
Why?
| | Middle Aged | 2 | 2023 | 26605 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6077 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 118 | 0.030 |
Why?
| | Delphi Technique | 1 | 2014 | 157 | 0.030 |
Why?
| | Neuroglia | 1 | 2015 | 149 | 0.030 |
Why?
| | Exome | 1 | 2015 | 200 | 0.030 |
Why?
| | Myelin Sheath | 1 | 2015 | 138 | 0.030 |
Why?
| | Citrate (si)-Synthase | 1 | 2013 | 45 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2013 | 53 | 0.030 |
Why?
| | North America | 1 | 2013 | 255 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 301 | 0.030 |
Why?
| | Consensus | 1 | 2014 | 532 | 0.030 |
Why?
| | Chemokine CCL4 | 1 | 2011 | 21 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 534 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 590 | 0.020 |
Why?
| | Aged | 1 | 2009 | 18969 | 0.020 |
Why?
| | Betaine | 1 | 2011 | 63 | 0.020 |
Why?
| | Interleukin-1alpha | 1 | 2011 | 55 | 0.020 |
Why?
| | Northwestern United States | 1 | 2010 | 52 | 0.020 |
Why?
| | Southwestern United States | 1 | 2010 | 90 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 662 | 0.020 |
Why?
| | Interleukin-17 | 1 | 2011 | 104 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2013 | 367 | 0.020 |
Why?
| | Patient Care Management | 1 | 2010 | 53 | 0.020 |
Why?
| | Binding Sites | 1 | 2013 | 1166 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 209 | 0.020 |
Why?
| | Public Health Practice | 1 | 2010 | 61 | 0.020 |
Why?
| | DNA Polymerase gamma | 1 | 2010 | 7 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2011 | 368 | 0.020 |
Why?
| | Family Health | 1 | 2010 | 193 | 0.020 |
Why?
| | Information Dissemination | 1 | 2010 | 185 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 376 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1888 | 0.020 |
Why?
| | Gastrointestinal Diseases | 1 | 2010 | 182 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 441 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2010 | 622 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 673 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1690 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2009 | 410 | 0.020 |
Why?
| | Linear Models | 1 | 2009 | 768 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2013 | 2550 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1128 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2011 | 1947 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2384 | 0.020 |
Why?
| | Proteomics | 1 | 2011 | 815 | 0.020 |
Why?
| | Myoclonic Epilepsy, Juvenile | 1 | 2004 | 1 | 0.020 |
Why?
| | Mice | 2 | 2011 | 14843 | 0.020 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2004 | 12 | 0.020 |
Why?
| | Nystagmus, Pathologic | 1 | 2004 | 7 | 0.020 |
Why?
| | Apnea | 1 | 2004 | 17 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 2562 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2322 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 2764 | 0.010 |
Why?
| | Hydrocephalus | 1 | 2004 | 83 | 0.010 |
Why?
| | Health Surveys | 1 | 2004 | 441 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1206 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2004 | 528 | 0.010 |
Why?
| | Sex Factors | 1 | 2004 | 1706 | 0.010 |
Why?
| | Disease Progression | 1 | 2004 | 2371 | 0.010 |
Why?
| | Registries | 1 | 2004 | 1764 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2004 | 4595 | 0.010 |
Why?
|
|
Van Hove's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|